Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. by Zhao, Yang et al.
www.thelancet.com/lancetgh   Vol 8   June 2020 e840
Articles
Lancet Glob Health 2020; 
8: e840–49
See Comment page e750
The Nossal Institute for Global 
Health, Melbourne School of 
Population and Global Health, 
The University of Melbourne, 
Melbourne, VIC, Australia 
(Y Zhao PhD, 
Prof B Oldenburg PhD, 
Prof B McPake PhD, J Lee PhD); 
WHO Collaborating Centre on 
Implementation Research for 
Prevention and Control of 
Noncommunicable Diseases, 
Melbourne, VIC, Australia 
(Y Zhao, Prof B Oldenburg); 
The George Institute for Global 
Health at Peking University 
Health Science Center, Beijing, 
China (Y Zhao); Department of 
Global Health and Population, 
Harvard T H Chan School of 
Public Health and Department 
of Global Health and Social 
Medicine, Harvard Medical 
School, Harvard University, 
Boston, MA, USA 
(Prof R Atun FRCP); Duke Global 
Health Institute, Duke 
University, Durham, NC, USA 
(Prof S Tang PhD); Usher 
Institute, College of Medicine 
and Veterinary Medicine, 
University of Edinburgh, 
Edinburgh, UK 
(Prof S W Mercer PhD); 
Department of Health Services 
Research and Policy, London 
School of Hygiene & Tropical 
Medicine, London, UK 
(T E Cowling PhD); Saw Swee 
Hock School of Public Health, 
National University of 
Singapore, Singapore 
(G Sum PhD, V M Qin PhD); and 
Public Health Policy Evaluation 
Unit, Department of Primary 
Care and Public Health, School 
of Public Health, Imperial 
College London, London, UK 
(J T Lee PhD)
Physical multimorbidity, health service use, and catastrophic 
health expenditure by socioeconomic groups in China: 
an analysis of population-based panel data
Yang Zhao, Rifat Atun, Brian Oldenburg, Barbara McPake, Shenglan Tang, Stewart W Mercer, Thomas E Cowling, Grace Sum, Vicky Mengqi Qin, 
John Tayu Lee
Summary
Background Multimorbidity, the presence of two or more mental or physical chronic non-communicable diseases, is 
a major challenge for the health system in China, which faces unprecedented ageing of its population. Here we 
examined the distribution of physical multimorbidity in relation to socioeconomic status; the association between 
physical multimorbidity, health-care service use, and catastrophic health expenditures; and whether these associations 
varied by socioeconomic group and social health insurance schemes.
Methods In this population-based, panel data analysis, we used data from three waves of the nationally representative 
China Health and Retirement Longitudinal Study (CHARLS) for 2011, 2013, and 2015. We included participants aged 
50 years and older in 2015, who had complete follow-up for the three waves. We used 11 physical non-communicable 
diseases to measure physical multimorbidity and annual per-capita household consumption spending as a proxy for 
socioeconomic status.
Findings Of 17 708 participants in CHARLS, 11 817 were eligible for inclusion in our analysis. The median age of 
participants was 62 years (IQR 56–69) in 2015, and 5766 (48·8%) participants were male. 7320 (61·9%) eligible 
participants had physical multimorbidity in China in 2015. The prevalence of physical multimorbidity was increased 
with older age (odds ratio 2·93, 95% CI 2·71–3·15), among women (2·70, 2·04–3·57), within a higher socioeconomic 
group (for quartile 4 [highest group] 1·50, 1·24–1·82), and higher educational level (5·17, 3·02–8·83); however, 
physical multimorbidity was more common in poorer regions than in the more affluent regions. An additional 
chronic non-communicable disease was associated with an increase in the number of outpatient visits (incidence rate 
ratio 1·29, 95% CI 1·27–1·31), and number of days spent in hospital as an inpatient (1·38, 1·35–1·41). We saw similar 
effects in health service use of an additional chronic non-communicable disease in different socioeconomic groups 
and among those covered by different social health insurance programmes. Overall, physical multimorbidity was 
associated with a significantly increased likelihood of catastrophic health expenditure (for the overall population: 
odds ratio 1·29, 95% CI 1·26–1·32, adjusted for sociodemographic variables). The effect of physical multimorbidity 
on catastrophic health expenditures persisted even among the higher socioeconomic groups and across all health 
insurance programmes.
Interpretation Concerted efforts are needed to reduce health inequalities that are due to physical multimorbidity, and 
its adverse economic effect in population groups in China. Social health insurance reforms must place emphasis on 
reducing out-of-pocket spending for patients with multimorbidity to provide greater financial risk protection.
Funding None.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Chronic conditions are a major contributor to health 
burden, inequalities in health outcomes, and economic 
burden in China.1,2 With an ageing population and 
high levels of risk factors for non-communicable 
diseases, the prevalence of multimorbidity (defined as 
two or more coexisting chronic conditions3) is likely 
to increase rapidly.4 Despite the increasing prevalence 
of multimorbidity, little attention has been given to 
its implications for individuals, households, health 
systems, and the economy in China.5
The Chinese Government, via its Healthy China 2030 
Plan6 and through a series of far-reaching health reforms, 
has set a bold vision for achieving universal health 
coverage and reducing premature mortality due to non-
communicable diseases by 30% from 2015 to 2030. As of 
2011, approximately 1·2 billion Chinese citizens (more 
than 95·7%  of the total population of 1·3 billion people) 
are covered by one of three social health insurance 
programmes: the Urban Employee Basic Medical 
Insurance (UEBMI) scheme, the Urban Resident Basic 
Medical Insurance (URBMI) scheme, and the New Rural 
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Cooperative Medical Scheme (NRCMS; panel).7,10 To 
improve fairness in health insurance coverage, the 
central government in China announced the decision to 
integrate URBMI and NRCMS into the new Urban-Rural 
Resident Medical Insurance (URRMI) scheme at the end 
of 2015.11 However, low levels of service coverage for 
some beneficiaries and high levels of patient cost-sharing 
(from out-of-pocket fees for health services) have raised 
concerns about the lack of adequate financial protection 
for patients with non-communicable diseases.10
The economic impact of multimorbidity and its impli-
cations on financial stress has been an emerging area 
of research for the past 10 years.4 To date, the evidence 
on the economic burden of multimorbidity is mostly 
from high-income countries. This evidence suggests that 
multi morbidity imposes high economic costs on indi-
viduals and households.12 Patients with multimorbidity 
incur substantial health expenditures due to their con-
ditions,13 and are more likely to be absent from work and 
less productive, with adverse economic conse quences.12 
However, the associ ations between multimorbidity, health 
service use, and levels of financial stress in different 
population groups have not been widely examined in low-
income and middle-income countries.
In China, little evidence exists on the economic effect 
of multimorbidity on individuals and the health system. 
To date, published studies have examined regional-level 
or district-level populations and used cross-sectional 
study designs.14–16 None of these studies has used nation-
ally representative panel survey data. We present the first 
study from China that uses panel survey data for the 
period 2011–15 to examine physical multimorbidity, its 
association with socioeconomic status, and its effect on 
health service use and catastrophic health expenditure. 
The data are representative of the largest middle-aged 
and older population group (people aged ≥50 years) in 
the world, comprising more than 337 million people.17
Methods
Study design and data sources
In this population-based, panel data analysis we used 
data from the three waves of the China Health and 
Retirement Longitudinal Study (CHARLS) run in 2011, 
2013, and 2015.18 Briefly, CHARLS collects high-quality 
data via one-to-one interviews with a structured 
questionnaire, from a nationally representa tive sample of 
Chinese residents aged 45 years and older, selected using 
multistage stratified probability-proportionate-to-size 
sampling. The overall response rate to CHARLS was 
80·5% in the first wave. The total sample size of the 
CHARLS baseline survey in 2011 was 17 708 individual 
respondents and these participants were followed up 
once every 2 years to repeat the survey. The data included 
individual weighting variables to ensure that the survey 
sample was nationally repre sentative. A detailed descrip-
tion of the objectives and methods of CHARLS has been 
reported elsewhere.18
The Biomedical Ethics Review Committee of Peking 
University approved CHARLS, and all participants were 
required to provide written informed consent. The 
ethical approval number was IRB00001052-11015.
For this study, we included data from participants who 
were not lost to follow-up over the three waves and aged 
50 years and older in wave three, and we excluded 
Research in context
Evidence before this study
We searched PubMed and MEDLINE for articles published in 
English between Jan 1, 1979, and Jan 31, 2019, using the 
keywords “multimorbidity”, “multiple chronic diseases”, 
“healthcare utilisation”, “economic burden”, “health 
expenditure”, and “China”. We identified 12 articles that 
examined the association between multimorbidity and 
health-care use and expenditure in China. One study examined 
the association between multimorbidity and health-care use 
among 162 464 people in Guangdong province. However, 
we identified no national-level studies that used panel survey 
data in their analysis to examine the effect of multimorbidity 
on health service use and financial protection by socioeconomic 
group and populations covered by various social health 
insurance schemes in China. Research is urgently needed to 
generate evidence to inform health policy and health system 
responses to multimorbidity.
Added value of this study
To our knowledge, this study is the first longitudinal analysis 
to examine socioeconomic group differences in the prevalence 
of physical multimorbidity in China, and its effect on health-
care use and catastrophic health expenditures. Our findings 
indicate that physical multimorbidity is common among 
Chinese adults aged 50 years and older. Individuals in higher 
socioeconomic groups have more physical multimorbidity 
than those in lower socioeconomic groups.
Implications of all the available evidence
Our findings differ from the evidence from high-income 
countries, where the prevalence of physical multimorbidity is 
higher among lower-income groups than in higher-income 
groups, but this difference might be due to limitations in the 
current study data, which excluded mental health conditions and 
relied mainly on self-report. Further studies examining the effect 
of multimorbidity due to other common chronic conditions 
(eg, Alzheimer’s disease, depression, asthma) and infectious 
diseases (eg, tuberculosis, AIDS, coronavirus disease 2019) are 
also warranted. The social patterning of multimorbidity in China 
requires further research that should include a wider range of 
morbidities, and more robust measures of both mental and 
physical conditions than has been recorded to date.
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participants who had missing values of dependent or 
independent variables.
Procedures 
In this study, we defined multimorbidity as the presence 
of two or more physical chronic non-communicable 
diseases.4 We used 11 non-communicable diseases to 
measure physical multimorbidity, including diagnosed 
hypertension and ten self-reported diagnosed chronic 
diseases (diabetes, dyslipidaemia, heart disease, stroke, 
cancer, chronic lung disease, digestive disease, liver disease, 
kidney disease, and arthritis). We counted the number of 
non-communicable diseases for each participant to identify 
those who had physical multi morbidity. We did not include 
individuals with self-reported psychiatric and memory-
related diseases due to potential recall bias.
In CHARLS, each respondent’s systolic and diastolic 
blood pressure was recorded three times by a trained 
nurse using a HEM-7112 electronic monitor (OMRON, 
Tokyo, Japan). Diagnosed hypertension was defined as 
systolic blood pressure of 140 mm Hg or higher, diastolic 
blood pressure of 90 mm Hg or higher, being on anti-
hypertensive medication for increased blood pressure, or 
a combination of these factors.19
In CHARLS, participants were asked about their use of 
outpatient and inpatient services via the following 
questions: “How many times did you visit a general 
hospital, specialised hospital, clinic, or other medical 
facilities for outpatient care in the past month?” and 
“How many days did you stay in hospital over the past 
year?” CHARLS collected self-reported information on 
how much respondents paid in total and how much they 
paid out of pocket (deducting the reimbursed expenses) 
for their outpatient visits during the past month and for 
inpatient visits during the past year. We multiplied the 
monthly spending by 12 to calculate the annual out-of-
pocket spending for each participant for outpatient care. 
The same information was also collected for spouses 
of all participants. To calculate catastrophic health 
expenditures at the household level, we used the out-of-
pocket spending data for spouses as well.
We defined a household as incurring catastrophic 
health expenditures when out-of-pocket spending on 
health equalled or exceeded 40% of a household’s capacity 
to pay.20 We defined a household’s capacity to pay as the 
total consumption expenditure of the household minus 
the food-based household spending. This expenditure 
level was the denominator and the numerator was the 
sum of participant’s and their spouses’ out-of-pocket 
spending for outpatient and inpatient care in the past 
year. We defined a binary variable, which indicated 
whether the participant’s house hold had catastrophic 
health expenditures or not.
We analysed differences between socioeconomic groups. 
We used annual per-capita household consumption 
spending as a proxy for socioeconomic status. We defined 
four socioeconomic groups on the basis of quartiles of 
per-capita household consumption expenditure (quartile 1, 
<US$662·50; quartile 2, $662·50 to <1203·00; quartile 3, 
$1203·00 to <2151·50; and quartile 4 ≥$2151·5).
We included the following variables as covariates: age, 
sex, marital status (married and partnered, unmarried, 
and others), education (primary school and below, 
secondary school, and college and above), residence (rural, 
urban, and rural-to-urban, defined as people with 
agricultural household registration but living in urban 
areas), socioeconomic status quartiles, health insurance 
(UEBMI, URBMI, NRCMS, other insurance, and without 
insurance), and economic development region (five 
regional classes). Overall, we identified five economic 
development regions and ranked them on the basis of 
their 2015 gross domestic product per-capita income at the 
province level in China (group 1, >$12 000; group 2, 
$12 000 to >10 000; group 3, $10 000 to >7000; group 4, 
$7000 to >6000; and group 5, ≤$6000).21
Statistical analysis
We used a panel data approach of random-effects logistic 
regression to examine the associations between socio eco-
nomic status and the presence of physical multi morbidity. 
Panel: China’s main social health insurance schemes
The China New Health System Reform, introduced in 2009, has expanded social health 
insurance coverage such that in 2011 95·7% of the Chinese population were covered.7 
Three main social health insurance schemes exist.
The UEBMI scheme, which covers urban workers, was launched by the Chinese State 
Council in 1998. All urban employees are required to join this scheme, which consists of a 
pooled fund for inpatient stays and individual medical savings accounts for outpatient 
visits. Approximately 283 million people were enrolled in UEBMI in 2014.8 It is financed by 
payroll income from employees (2% of their salary) and employers (equivalent to 6% of 
employee’s salary).9 The per-capita fund of this scheme is US$424·7.10
The URBMI scheme aims to insure the rest of the urban population, including children, 
students, and other unemployed urban residents who are not covered by UEBMI. 
In 2014, 315 million people were covered by URBMI. The scheme is funded by a 
government subsidy (70%) and individual contributions (30%).9 The per-capita fund of 
this scheme is $66·2.10
The NRCMS was launched in 2003 for the rural population, and expanded rapidly to cover 
about 802 million rural residents by 2013.10 NRCMS funds are pooled at the county level. 
The NRCMS is financed by the premiums of those enrolled (approximately 20%) and 
generous subsidies from both central and local governments (approximately 80%). 
Annual government subsidies per enrolee increased from ¥20 (US$2·9) in 2003 to ¥380 
($55·2) in 2015. The per-capita funding for NRCMS is $61·2.9
China has also established a medical assistance programme for subsistence allowance 
recipients, people in poverty, low-income household members, and critically-ill patients in 
poor families. This programme is jointly funded by the central and local governments. 
At the end of 2015, the Chinese Government announced the decision to integrate URBMI 
and NRCMS as the URRMI scheme, to achieve universal health coverage.11 This integration 
has enabled a further extension of funding pools and narrowing of disparities in access to 
health-care services and medications, which existed between different insurance schemes.
UEBMI=Urban Employee Basic Medical Insurance. URBMI=Urban Resident Basic Medical Insurance. NRCMS=New Rural 
Cooperative Medical Scheme. URRMI=Urban-Rural Resident Medical Insurance.
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We used random-effects negative binomial regression 
models to investigate the association between the number 
of non-communicable diseases and the number of 
outpatient visits and inpatient hospital days. We adopted a 
negative binomial model instead of a Poisson regression 
model because the variances were greater than the means 
in outcome variables (appendix pp 4–5), suggesting that 
overdispersion was present in the outcome variables 
(likelihood ratio test of α=0, p<0·001). The negative 
binomial model allows for over dispersion by assuming 
that the individual error terms come from a particular 
probability distribution (the γ distribution).22 We used a 
random-effects logistic regression model to estimate the 
association between the number of non-communicable 
diseases and the likelihood of catastrophic health 
expenditure.
To explore the differential effect in population groups, 
we did subgroup analyses, stratified by socioeconomic 
status and membership of insurance schemes, using the 
same regression analyses but with the stratification 
variable removed.
For the logistic regression analyses, we report 
associations as odds ratios (ORs) adjusted for age, 
sex, marital status, education, residence, socioeconomic 
status quartiles, health insurance, and economic 
development regions, with 95% CIs. For the negative 
binomial regression analysis, we report incidence rate 
ratios (IRRs) adjusted for age, sex, marital status, 
education, residence, socioeconomic status quartiles, 
health insurance, and economic development regions, 
with 95% CIs.
We did three sensitivity analyses. First, we examined 
factors associated with the number of multimorbid con-
ditions using a random-effects Poisson regression model 
with robust standard error. Second, we investi gated the 
association between the number of non-communicable 
diseases, outpatient visits, and inpatient hospital days 
using a Poisson model instead of a negative binomial 
model. Finally, we used the WHO and World Bank’s 
definitions of catastrophic health expenditure at various 
thresholds: 10% and 25% of the total household con-
sumption expenditure by WHO definitions and 25% and 
40% of the non-food household consumption expenditure 
by World Bank definitions.20
All descriptive analyses were weighted to account for 
the complex, multistage design of the study, and non-
response in the CHARLS data. Other studies using 
CHARLS data, including CHARLS reports, suggest that 
results from regression analyses with and without 
weighting are similar.23 We considered p values of less 
than 0·05 to be significant.
Adjusted odds 
ratio (95% CI)*
p value
Socioeconomic group
Quartile 1 (lowest) 1 (ref) ··
Quartile 2 1·13 (0·96–1·34) 0·15
Quartile 3 1·25 (1·04–1·49) 0·016
Quartile 4 (highest) 1·50 (1·24–1·82) <0·0001
Age, per 5 years 2·93 (2·71–3·15) <0·0001
Sex
Male 1 (ref) ··
Female 2·70 (2·04–3·57) <0·0001
Marital status
Married 1 (ref) ··
Unmarried and others 1·37 (1·03–1·82) 0·030
Education
Primary school and below 1 (ref) ··
Secondary school 9·27 (5·85–14·67) <0·0001
College and above 5·17 (3·02–8·83) <0·0001
Residence status
Urban 1 (ref) ··
Rural 0·59 (0·41–0·85) 0·005
Rural-to-urban 0·76 (0·53–1·10) 0·14
Economic development region
Group 1 (most affluent) 1 (ref) ··
Group 2 5·37 (3·10–9·31) <0·0001
Group 3 4·06 (2·42–6·82) <0·0001
Group 4 3·25 (2·10–5·02) <0·0001
Group 5 (most deprived) 3·88 (2·25–6·69) <0·0001
Health insurance
None 1 (ref) ··
Urban Employee Basic Medical Insurance 0·92 (0·63–1·35) 0·68
Urban Resident Basic Medical Insurance 0·84 (0·58–1·20) 0·33
New Rural Cooperative Medical Scheme 0·81 (0·62–1·04) 0·10
Others† 0·77 (0·47–1·24) 0·28
*Adjusted for age, sex, marital status, education, residence, socioeconomic status 
quartiles, health insurance, and economic development regions. †Examples 
include government health care, private medical insurance.
Table 1: Longitudinal analysis of determinants of multimorbidity 
among people aged 50 years and older in China, 2011–15
Figure 1: Prevalence of physical multimorbidity in China, by age and 
socioeconomic status, in 2015
On the socioeconomic status scale, quartile 1 is the lowest quartile and quartile 4 
is the highest quartile.
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We did all statistical analyses using Stata (version 15.0).
Role of the funding source
There was no funding source for this study. The 
corresponding author had full access to all the data in the 
study and had final responsibility for the decision to 
submit for publication.
Results
Of the 17 708 participants in CHARLS, we identified 
13 565 without loss to follow-up, of whom 11 817 were 
eligible for inclusion in our analysis. Eligible partici-
pants’ socioeconomic and socio demographic character-
istics are shown in the appendix (pp 1–2). The median 
age of participants was 62 years (IQR 56–69) in 
2015. 5766 (48·8%) participants were male, 6051 (51·2%) 
were female, and 10 036 (84·9%) were married or part-
nered. 8144 (68·9%) participants had primary education or 
below, and 7650 (64·7%) were residing in rural areas. 
10 933 (92·5%) had at least one kind of health insurance, 
with 8808 (74·5%) respondents enrolled in the NRCMS.
The proportion of people with physical multimor-
bidity  increased substantially with age. In 2015, the 
overall prevalence of physical multimorbidity was 61·9% 
(7320 of 11 817), with 1209 (51·7%) of 2339 aged 50–54 years 
having physical multimorbidity and 978 (68·5%) of 
1427 aged 75 years and above having physical 
multimorbidity (appendix p 3).
Number of outpatient visits Inpatient hospital days Catastrophic health expenditure
Adjusted incidence 
rate ratio*
p value Adjusted incidence 
rate ratio*
p value Adjusted odds 
ratio*
p value
Number of non-communicable diseases 1·29 (1·27–1·31) <0·0001 1·38 (1·35–1·41) <0·0001 1·29 (1·26–1·32) <0·0001
Age, per 5 years 1·00 (0·98–1·02) 0·85 1·17 (1·15–1·20) <0·0001 1·14 (1·12–1·17) <0·0001
Sex
Male 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Female 1·24 (1·17–1·31) <0·0001 0·93 (0·87–1·01) 0·079 0·97 (0·90–1·04) 0·42
Marital status
Married 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Unmarried or other 1·03 (0·95–1·11) 0·53 0·97 (0·87–1·07) 0·52 0·40 (0·35–0·46) <0·0001
Education
Primary school and below 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Secondary school 0·99 (0·92–1·06) 0·74 0·97 (0·88–1·08) 0·57 1·01 (0·92–1·11) 0·84
College and above 1·00 (0·90–1·11) 0·99 0·85 (0·74–0·98) 0·026 0·91 (0·80–1·04) 0·17
Residence status
Urban 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Rural 1·29 (1·15–1·43) <0·0001 1·01 (0·88–1·16) 0·87 1·29 (1·12–1·48) 0·0010
Rural-to-urban 1·23 (1·10–1·39) 0·0010 1·15 (0·99–1·34) 0·064 1·12 (0·96–1·31) 0·15
Economic development region
Group 1 (most affluent) 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Group 2 1·06 (0·95–1·18) 0·28 1·19 (1·02–1·38) 0·028 1·22 (1·06–1·41) 0·0070
Group 3 0·96 (0·85–1·08) 0·50 1·51 (1·29–1·78) <0·0001 1·23 (1·05–1·43) 0·011
Group 4 1·27 (1·15–1·40) <0·0001 1·52 (1·32–1·75) <0·0001 1·32 (1·15–1·50) <0·0001 
Group 5 (most deprived) 1·00 (0·89–1·13) 0·95 1·70 (1·45–1·20) <0·0001 1·04 (0·89–1·22) 0·63
Socioeconomic group
Quartile 1 (the lowest) 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Quartile 2 1·10 (1·03–1·18) 0·0080 1·16 (1·05–1·28) 0·0040 0·97 (0·88–1·06) 0·45
Quartile 3 1·09 (1·01–1·17) 0·023 1·48 (1·35–1·63) <0·0001 1·01 (0·92–1·11) 0·83
Quartile 4 (the highest) 1·20 (1·11–1·29) <0·0001 1·77 (1·61–1·96) <0·0001 0·99 (0·89–1·09) 0·80
Health insurance
None 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Urban Employee Basic Medical Insurance 1·31 (1·11–1·55) 0·0010 1·56 (1·27–1·90) <0·0001 0·98 (0·79–1·21) 0·84
Urban Resident Basic Medical Insurance 1·25 (1·05–1·48) 0·013 1·35 (1·09–1·67) 0·0060 1·14 (0·91–1·42) 0·25
New Rural Cooperative Medical Scheme 1·39 (1·22–1·58) <0·0001 1·36 (1·16–1·60) <0·0001 1·34 (1·14–1·57) <0·0001 
Others† 1·35 (1·09–1·68) 0·0060 1·19 (0·91–1·57) 0·20 0·87 (0·65–1·17) 0·35
*Adjusted for age, sex, marital status, education, residence, socioeconomic status quartiles, health insurance, and economic development regions. †Examples include 
government health care, private medical insurance.
Table 2: The association between the number of non-communicable diseases and health service use and spending in China, 2011–15
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The prevalence of physical multimorbidity increased 
with increasing socioeconomic status. For example, 
among people aged 50–54 years, 204 (50·3%) of 406  in the 
lowest socioeconomic quartile had physical multimorbidity 
versus 365 (53·9%) of 677 in the highest quartile (figure 1). 
Overall, the prevalence of physical multi morbidity in the 
highest socioeconomic quartile in a given age group 
was often similar to the prevalence in the lowest socio-
economic quartile in the next youngest age group.
Participants in the highest socioeconomic quartile 
were more likely to report physical multimorbidity, 
than those in the quartile with the lowest economic 
status (adjusted OR 1·50, 95% CI 1·24–1·82; table 1). 
Participants with higher educational attainment were 
more likely to report having physical multimorbidity 
than those with lower educational attainment.
Additionally, the prevalence of physical multimorbidity 
was higher in women than in men, and was higher in the 
most deprived region than in the most affluent region 
(table 1). We did not find an association between health 
insurance status and prevalence of physical multimorbidity 
(table 1).
Additional chronic non-communicable disease was 
associated with an increase in the number of outpatient 
visits and inpatient hospital days (table 2). Overall, the 
associations between the presence of additional non-
communicable diseases and health service use were 
similar across socioeconomic groups—ie, for each 
socioeconomic group, those with an additional non-
communicable disease had greater health service use 
(figures 2, 3). Moreover, differences between socio-
economic groups in the association between physical 
multimorbidity and outpatient visits were similar across 
health insurance schemes (figure 2). A similar pattern 
was seen for the number of days spent in hospital as an 
inpatient (figure 3).
A higher number of non-communicable diseases was 
associated with increased likelihood of catastrophic 
health expenditures (table 2). The effect of physical 
multimorbidity on catastrophic health expenditures 
persisted even in the highest socioeconomic quartile 
and those with more generous health insurance 
coverage  (eg, UEBMI; panel, figure 4).
We did three sensitivity analyses. First, we examined 
factors associated with the number of multimorbid 
conditions (appendix p 6). Consistent with our main 
findings, the likeli hood of having an increased number 
of multimorbid conditions was increased with older 
age, among women, and in the highest socioeconomic 
group, and in the most deprived regions (p<0·01). 
However, lower educational attainment was found 
to be associated with slightly lower number of non-
communicable diseases (IRR 0·95 [95% CI 0·92–0·99] 
for those who completed secondary school; and 
IRR 0·94 [0·89–0·99] for those who completed a college 
course, compared with those who completed primary 
school and below). Second, we investigated the associ-
ation between number of non-communicable diseases 
and number of outpatient visits and inpatient hospital 
days (appendix p 7). The results were consistent with 
our main findings, showing physical multi morbidity 
was associated with an increase in the number of 
outpatient visits and inpatient hospital days. Finally, we 
repeated our catastrophic health expenditure analysis 
using the WHO and World Banks’s definitions at 
various household expenditure thresholds. We found 
similar associations between physical multimorbidity 
and catastrophic health expendi tures at different 
thresholds (appendix p 8).
Discussion
To our knowledge, this study is the first panel data 
analysis of a nationally representative longitudinal survey 
of middle-aged and older Chinese people—representing a 
population group of more than 300 million people17—
which examined differences between socioeconomic 
groups in the prevalence of physical multimorbidity, and 
the effect of these differences on health-care use and the 
risk of catastrophic health expenditure.14 We found that 
physical multimorbidity is common among Chinese 
people aged 50 years and older. The likelihood of physical 
multimorbidity increased with older age, among women, 
with higher per capita household expenditure (ie, in 
higher socioeconomic groups), and possibly with higher 
Figure 2: Association between physical multimorbidity and number outpatient visits by health insurance 
scheme and economic status
UEBMI=Urban Employee Basic Medical Insurance. URBMI=Urban Resident Basic Medical Insurance. NRCMS=New 
Rural Cooperative Medical Scheme. None=people without health insurance. IRR=incidence rate ratio.
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educational level (although our sensitivity analysis did not 
support this finding). However, physical multimorbidity 
was more common in the most deprived regions than 
in the most affluent regions. Our findings suggest a 
significant association between physical multimorbidity 
in higher socioeconomic groups in China, at least when 
measured using household per-capita consumption 
expenditure as a proxy.
The number of chronic non-communicable diseases 
was positively associated with increased use of both 
outpatient and inpatient care. This association appeared 
to be similar across socioeconomic groups and health 
insurance schemes. Physical multimorbidity was 
associated with increased likelihood of catastrophic 
health expenditure, with similar effect sizes between the 
highest and lowest income groups. Because greater 
absolute levels of expenditures are required to trigger the 
so-called catastrophic expenditure threshold for those in 
higher income brackets than those in lower brackets, 
these results suggest that people in higher socioeconomic 
groups might have more intensive health-care use or use 
more expensive health-care services than those in lower 
socioeconomic groups.
We found that people with a higher socioeconomic 
status had a greater prevalence of multimorbid conditions 
than those in lower socioeconomic groups, across all age 
categories analysed. This finding might be partly explained 
by the fact that people in higher-income groups, who have 
better access to health-care services and better health 
literacy, are more likely to have their non-communicable 
diseases diagnosed (or even over diagnosed) than people 
in lower-income groups.24,25 Furthermore, the recall of 
specific chronic conditions that have been diagnosed in 
the past, might be improved in those in higher socio-
economic groups, for example, because they are paying 
for ongoing treatment. Also, low capacity and accessibility 
of rural facilities could mean that physical multimorbidity 
is under-reported in rural areas. Our results might reflect 
a combination of true underlying prevalence, access to 
health care, and health literacy.
Our findings contrast with evidence from high-income 
countries that shows an increased prevalence of multi-
morbidity in populations with low socioeconomic 
status.26,27 For instance, a study of 16 European countries 
found that individuals in the highest income quintile and 
those with higher levels of education were less likely to 
have physical multimorbidity than those with lower levels 
of income and education.26 Our findings are consistent 
with other studies that have examined physical multi-
morbidity in low-income and middle-income countries 
(eg, India and Bangladesh), which found that obesity, 
physical inactivity, and con sumption of tobacco, alcohol, 
fat, salt, and processed food are more prevalent among 
high socio economic groups.24,28 These differences in 
findings might be due to low-income and middle-income 
countries being in an earlier stage of the epidemiological 
transition than high-income countries are.29,30 Additionally, 
most studies in high-income countries include mental 
health conditions in their measurement of multimorbidity, 
and most of the excess multimorbidity in lower socio-
economic groups is accounted for by the combination of 
mental and physical multi morbidity.27 Here, we did not 
include mental health conditions in our calculation of 
multimorbidity.
In all socioeconomic quartiles, levels of multimorbidity 
are increasing. For any individual, given that a chronic 
condition might not be resolved, the likelihood of 
multimorbid conditions increases with older age. We 
observed a decrease in the prevalence of physical 
multimorbidity in the lowest socioeconomic group from 
those aged 70–74 years to those aged 75 years and older, 
which might indicate a cohort effect (and a chance 
variation), suggesting that those aged 75 years and older 
were less exposed to relevant risk factors than the younger 
cohorts. These findings are consistent with the explanation 
of increasing cumulative exposure to risk factors over 
time by Lynch and Smith,31 in which the accumulation 
of chronic conditions over an individual’s lifespan, 
differential exposure according to socioeconomic status, 
and the adoption of lifestyles associated with risk factors 
increasing over the past few decades in the lowest 
socioeconomic group.32
Previous studies have shown that multimorbidity is 
associated with substantially increased use of health care, 
Figure 3: Association between physical multimorbidity and inpatient hospital days by health insurance 
scheme and economic status
UEBMI=Urban Employee Basic Medical Insurance. URBMI=Urban Resident Basic Medical Insurance. NRCMS=New 
Rural Cooperative Medical Scheme. None=people without health insurance. IRR=incidence rate ratio.
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and this association has been well documented in high-
income countries,26,33 and other studies in China.14,16 
However, to date, no studies have assessed the differences 
in this association due to socioeconomic group and 
health insurance schemes in China.34 Our study provides 
new evidence on the association between physical 
multimorbidity and use of health services across 
socioeconomic groups enrolled in different insurance 
schemes. We found no different effects of physical 
multimorbidity on health-care use between groups with 
different types of insurance.
Consistent with previous studies, the presence of an 
increased number of chronic non-communicable 
conditions was associated with increased health 
expenditure.16,24 Although this association generally 
appeared to be similar across different socioeconomic 
groups in our study, our research also shows that the 
effect of multimorbidity on catastrophic health expen-
diture was increased for individuals at lower socio-
economic levels in the population covered by URBMI. A 
possible explanation for this observation is that less 
financial risk protection was available to people in the 
lowest income quartile who were enrolled in URBMI due 
to restricted benefits packages and a lack of coverage for 
some medications and inpatient services, which has 
probably led to a high incidence of catastrophic health 
expenditures. The cost of health care in urban health 
facilities is higher than that of rural health facilities. This 
difference could explain why lower socioeconomic 
groups covered by URBMI had a higher likelihood of 
catastrophic health expendit ures than those covered by 
UEBMI. A previous study has indicated that the per-
capita annual fund contribution for UEBMI was about 
six times higher than that for URBMI, suggesting that 
beneficiaries of UEBMI are likely to have smaller out-of-
pocket spending than individuals enrolled in URBMI.9
Our study had several limitations. First, the use of self-
reported measures of chronic disease and health-care use 
might have underestimated their prevalence, particularly 
among older people and those from lower socioeconomic 
and educational backgrounds who might be more likely 
to under-report these factors. Second, the CHARLS 
questionnaire did not ask about all chronic diseases 
typically included in clinical database studies. Further 
studies examining the effect of multimorbidity due to other 
common chronic conditions (eg, Alzheimer’s disease, 
depression, asthma) and infectious diseases (eg, tubercu-
losis, AIDS, coronavirus disease 2019) are also warranted. 
The social patterning of multimorbidity in China requires 
further research that should include a wider range of 
morbidities, and more robust measures of both mental and 
physical conditions than has been recorded to date. Finally, 
this study only included people from China aged 50 years 
and older in 2015. The prevalence of multimorbidity and its 
effect among younger populations should be considered in 
future studies.
Our findings provide new evidence to inform the 
development of targeted policies and interventions to 
tackle the increasing burden of physical multimorbidity in 
China. Health systems need to shift from single-disease 
models to new methods of financing and service delivery 
to more effectively manage multimorbidity.35 Strong 
primary health care, underpinned by multidisciplinary 
teams, is essential for cost-effective manage ment of multi-
morbidity.4 In 2009, China began to rebuild its primary 
health care by developing community health centres, 
although progress has been mixed.36 A trial in China that 
is testing the roll-out of the so-called people-centred 
integrated care programme, which incentivises primary 
health-care centres to manage patients with chronic 
diseases holistically, is an example of such a new 
approach.37
Disease-specific guidelines are inadequate for the 
effective management of individuals with multimorbid 
conditions and new clinical guidelines for multimorbidity 
are needed. Countries such as the UK and Sri Lanka have 
developed clinical guidelines for multimorbidity that 
emphasise integration and patient-centred health-care 
services.38
Our findings also provide new evidence on the growing 
financial burden of multimorbidity in China. Multi-
morbidity is costly to individuals and health systems. Out-
of-pocket spending on medi cines can severely compromise 
financial risk protection.16,39 A 2015 systematic review of 
studies on Chinese populations showed that as the 
Figure 4: Association between physical multimorbidity and risk of catastrophic health expenditure by health 
insurance scheme and economic status
UEBMI=Urban Employee Basic Medical Insurance. URBMI=Urban Resident Basic Medical Insurance. NRCMS=New 
Rural Cooperative Medical Scheme. None=people without health insurance. OR=odds ratio.
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number of chronic diseases increases from one to two, 
an individual’s annual out-of-pocket health spending 
increased by an average of 5·2 times, and as the number 
increased from two to three, their annual out-of-pocket 
health expenditures increased by an average of 10·1 times.10
Concerted efforts are needed in China and other 
low-income and middle-income countries with ageing 
populations to reduce inequalities due to multimorbidity, 
and its adverse effect on financial risk protection. China, 
which has the largest ageing population in the world, 
should develop targeted policies to ensure appropriate 
health services and financial risk protection for indi-
viduals with multimorbidity, particularly those in low 
socioeconomic groups who are at an increased risk of 
catastrophic health expenditures.
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